134.70USD+0.25%Mkt Cap: 167.26B USDP/E: 18.33Last update: 2026-05-26
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, D…
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap167.26B USD
Enterprise Value174.30B USD
Revenue (TTM)29.74B USD
Gross Profit23.21B USD
Net Income (TTM)8.51B USD
Revenue/Share23.92 USD
Last Price134.70 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS3755581036
Valuation
P/E (Trailing)18.33
P/E (Forward)13.61
PEG2.14
EV/EBITDA11.83
EV/Revenue5.86
P/S5.45
P/B7.13
EPS (TTM)7.35
EPS (Forward)9.59
52W Range
104.4657% of range157.29
52W High157.29 USD
52W Low104.46 USD
Profitability
Gross Margin78.83%
Oper. Margin39.28%
EBITDA Margin49.56%
Profit Margin28.90%
ROE37.49%
ROA14.42%
Growth
Revenue Growth4.40%
Earnings Growth54.80%
Cash Flow & Leverage
Operating CF10.02B USD
CapEx (TTM)563.00M USD
FCF Margin26.68%
FCF Yield4.74%
Net Debt12.36B USD
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity1.10
Current Ratio1.97
Quick Ratio1.54
Book Value/Sh18.29 USD
Cash/Share7.907 USD
Dividends
Fwd Div Rate3.280 USD
Trail. Div Rate3.190 USD
Div. Yield2.51%
5Y Avg Yield3.65%
Payout Ratio43.40%
Ex-Div DateJun 15, 2026
Pay DateJun 29, 2026
Splits
Last Split2:1
Split DateJan 28, 2013
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)157.83 USD
Target Range122.00 USD – 180.00 USD
# Analysts29
Ownership
Shares Out.1.24B
Float1.24B
Insiders0.12%
Institutions92.36%
Short Interest
Short Ratio4.2d
Short % Float1.86%
Short % Out.1.86%
Shares Short23.05M
Short (prev mo.)21.52M
Technical
SMA 50136.08 (-1.0%)
SMA 200128.20 (+5.1%)
Beta0.33
S&P 52W Chg28.31%
Avg Vol (30d)5.86M
Avg Vol (10d)6.02M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—